Inhibition of phospholipase A2 (PLA2), the enzyme that liberates arachidonic acid from membrane phospholipids, provides limited protection in stroke because the metabolism of polyunsaturated fatty acids (PUFA) is required to generate several anti-inflammatory eicosanoids [46] and epoxides [47]. This evidence concerns the gene PLA2G4A and stroke disorder.